Objectives: The purpose of this paper was to evaluate the use of air displacement plethysmography (ADP) in children and adolescents with cystic fibrosis (CF). Specifically, the primary aim of this study was to compare estimates of fat-free mass (FFM) measured from ADP and dual energy X-ray absorptiometry (DEXA) in children and adolescents with CF. The secondary aim was to compare the effect of using predicted thoracic gas volume (V TG ) and measured V TG for the calculation of FFM by ADP in this population. Methods: Cross-sectional FFM measurements were taken using ADP and DEXA in 52 children and adolescents with CF, ranging in age from 6.3 to 16.6 y. Results: Bland-Altman analysis showed that ADP values of FFM were on average 0.59 kg higher than DEXA values (95% limits of agreement ¼ 3.61 to À2.43 kg); however this difference was not significant. There was no significant correlation (r ¼ À0.26, P ¼ 0.07) between the mean FFM and difference in FFM between ADP and DEXA. Using either predicted or measured V TG did not significantly affect FFM estimates in individuals with CF who had normal lung function (bias ¼ À0.3970.86 kg; r ¼ À0.02, P ¼ 0.93). Conclusions: ADP is an appropriate technique for use in children and adolescents with CF.
Introduction
Cystic fibrosis (CF) is an inherited chronic illness of which the clinical features include exocrine pancreatic failure and chronic respiratory infection. Malnutrition is a substantial, but largely preventable complication for children and adolescents with CF. As malnutrition is recognised as a key factor that adversely affects lung function (Thomson et al, 1995; Steinkamp & Weidemann, 2002) and ultimately survival in those with CF (Corey et al, 1988) , nutritional care is considered a major component of CF management (Borowitz et al, 2002) . Nutritional status can be assessed by numerous body composition techniques, including skinfolds, bioelectrical impedance and total body potassium, but many of the available techniques have limitations that render them inappropriate for use in children and adolescents with CF (Lands et al, 1993; Stapleton et al, 2001) . It is important that the technique chosen to measure body composition in children and adolescents with CF is simple, painless, noninvasive and rapid to ensure it is accepted as a routine measurement by patients and clinicians.
A relatively new body composition technique that fits all these criteria and may be suitable for use in children and adolescents with CF is air displacement plethysmography (ADP) using the Bod Pod s Body Composition System (Life Measurement Inc., Concord, CA, USA). ADP uses the pressure and volume relationship of Poisson's law to determine body volume, which in turn can be used to determine density and consequently fat and fat-free mass (FFM) (Dempster & Aitkens, 1995) . ADP has been validated in adults (McCrory et al, 1995) , and recently investigated in healthy children and adolescents, where it was found to be an acceptable, reliable and accurate technique (Nunez et al, 1999; Dewit et al, 2000; Fields & Goran, 2000; Nicholson et al, 2001; Demerath et al, 2002) . However, to our knowledge no studies have examined the use of ADP in children and adolescents with CF.
The purpose of this paper was to evaluate the use of ADP for measuring body composition in children and adolescents with CF. To achieve this purpose, the primary aim of the paper was to investigate the agreement between ADP and the comparison method of dual energy X-ray absorptiometry (DEXA) for measuring FFM in children and adolescents with CF. For FFM calculations by ADP, either a predicted or measured thoracic gas volume (V TG ) can be used. However in those with CF, V TG may be increased or decreased depending on the severity of their lung disease. Although only 40% of V TG contributes to an FFM measurement, it is unknown whether FFM calculations are affected in those with CF by using the predicted V TG from the Bod Pod s vs a measured V TG . Therefore, the secondary aim was to examine whether using predicted V TG given by the Bod Pod s rather than measured V TG had any significant effect on the FFM calculation in a CF population.
Methods

Study sample
The study population included 52 children and adolescents (27 females) diagnosed with CF, aged between 6.3 and 16.6 y, who were recruited from the Royal Children's Hospital, Brisbane, Australia. The children and adolescents were part of a longitudinal study assessing bone growth and body composition. The Royal Children's Hospital Ethics Committee approved the study protocol, and both parental and subject consent were obtained.
Measurements
In preparation for the measurements, the subjects were requested to fast for 3 h prior to attending the laboratory. Subjects were weighed to the nearest 0.05 kg using calibrated digital scales (Tanita BWB-600, Wedderburn Scales, Australia) and height was measured to the nearest 0.1 cm using a wallmounted stadiometer (Holtain Instruments Ltd, Crymmych, UK). To describe the severity of lung disease, respiratory function tests were performed in accordance with the American Thoracic Society standards. Forced expiratory volume in 1 s (FEV 1 ) on the day and the best FEV 1 over the prior 6 months were recorded. FEV 1 was expressed as percentage predicted (Hibbert et al, 1989) . Body composition assessment was performed by ADP and DEXA measurements, in arbitrary order.
ADP. ADP measurement was performed using the Bod Pod s Body Composition System, adhering to the manufacturer's instructions (Life Measurement Inc., Concord, CA, USA; software version 1.69). A detailed description of the principles and procedures of ADP using the Bod Pod s is described in detail elsewhere (Dempster & Aitkens, 1995) .
Prior to each measurement, the Bod Pod s was calibrated at zero litres and with a standard calibration cylinder of 50 l. For the subject measurement, the ADP procedure requires that the subject wear a Lycra swimsuit and cap to minimise measurement error. Body volume measurements were taken as the subject sat inside the chamber for a 50-s period. The measurement was completed twice or until the body volume measurements were within 150 ml or 0.2% of each other, whichever was the smallest (maximum of three attempts). The average of the two successful measurements was taken.
The subject's V TG was then measured at mid-tidal exhalation, requiring the subject to breathe into a tube and follow the prompts during a 50-s period. Owing to time constraints, the subjects were only allowed two attempts to produce a measured V TG . All subjects were requested to perform the V TG measurement, although as not all subjects were able to perform a measured V TG within two attempts, predicted V TG values for each subject were also obtained. Predicted V TG was determined by the sum of functional residual capacity (FRC) and half tidal volume (TV), where FVC was calculated using the equations of Crapo et al (1982) and TV was assumed based on gender. To maintain consistency for the comparison between ADP and DEXA, predicted V TG was used to estimate body composition for all subjects. However, to examine the effect of V TG on ADP's measurement of FFM, both measured V TG and predicted V TG were used to estimate FFM in those subjects in whom a measured V TG was available. V TG , along with body volume, area artefact (correction for isothermal-like effects of the air near the skin) and mass were used to calculate body density (Dempster & Aitkens, 1995) . A paediatric-specific equation (Lohman, 1989) was then used to convert body density to body fatness and consequently, FFM.
DEXA. DEXA was used as the comparison technique. FFM (lean tissue þ bone mineral content) was determined using a Lunar DPX-L s pencil beam scan (Lunar Co, Madison, WI, USA) and paediatric software (version 4.71). The machine was calibrated daily using a three-chamber standard block of different known densities, supplied by the manufacturer. The short-term precision of our DEXA machine in vivo is 1% for bone mineral content and 3% for lean tissue mass and fat mass, and the accuracy of DEXA is reportedly between 1 and 3% for percent fat (Svendsen et al, 1993; Mitchell et al, 1998; Van der Ploeg et al, 2003) . Scans were performed while subjects wore light clothing and no metallic objects. One whole body scan was performed with the typical scan duration being 15-20 min depending on the height of the subject. The radiation dose for a total body DEXA scan was approximately 0.5 mSv.
Statistical analysis
Mean, standard deviation (s.d.) and range were used to describe the study sample. Z-scores were also recorded to enable comparison of height and weight of the study cohort to the general population. A paired t-test was used to examine the difference between the two methods. To determine the agreement between the techniques, FFM measurements from ADP and DEXA were compared using the method of Bland and Altman (1986) . The bias was calculated as the mean difference between the FFM measurements from each technique (all calculated as ADPÀDEXA) and the 95% limits of agreement were assessed as the bias 7 2sd. The correlation coefficient between the difference in FFM and the mean FFM from ADP and DEXA was calculated to determine if the bias was consistent across the range of FFM values. The effect of age, sex and percent fat (%fat) on the level of agreement was also examined.
The effect of using predicted V TG vs measured V TG for the calculation of FFM from ADP was compared in the group of subjects who were able to perform a measured V TG (n ¼ 29). For these subjects, FFM was calculated using both the predicted V TG and measured V TG . To investigate the difference between the measured and predicted V TG , and the difference between the FFM from measured V TG and predicted V TG , a paired t-test was used. Bland-Altman analysis was then used to assess the agreement between the resulting FFM values. Correlational analysis was used to investigate the consistency of the bias over the range of FFM measurements. Statistical significance was set at a P-value o0.05 for all analysis.
Results
A total of 52 (27 females) children and adolescents with CF who were able to perform both ADP and DEXA measurements were recruited. Basic characteristics of the subjects are shown in Table 1 . The mean Z-scores for height (P ¼ 0.008) and weight (P ¼ 0.03) were significantly lower than the general population. The mean lung function of the group was within normal limits, although the cohort did include individuals with significant lung disease as indicated by the large range in FEV 1 .
Body composition and V TG data are given in Table 2 . There was no significant difference between FFM from ADP or DEXA (P ¼ 0.72). The Bland-Altman comparison of ADP against DEXA is shown in Figure 1 . ADP values of FFM were, on average, higher than DEXA values by 0.5971.51 kg (%fat ¼ À2.275.0%), with the 95% limits of agreement being À2.43 to 3.61 kg (%fat ¼ À12.3-7.84%). The correlation between the difference in FFM and mean FFM from ADP and DEXA was not significant (r ¼ À0.26, P ¼ 0.07). Gender and %fat had no significant influence on the level of agreement between FFM derived from ADP and DEXA. However, the correlation between age and the difference between ADP and DEXA was significant (r ¼ À0.51, Po0.01).
From the total study population, 29 subjects (18 females; 11 males) with a mean age of 10.972.4 y were able to perform a measured V TG . In these subjects, there was a significant difference between the measured and predicted V TG (P ¼ 0.023), however there was no significant difference between FFM from measured and predicted V TG (P ¼ 0.20). 
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Bland-Altman analysis between FFM estimated using predicted V TG and FFM estimated using measured V TG showed a bias of À0.3970.86 kg (%fat ¼ 1.172.9%), with the 95% limits of agreement being À2.11 to 1.34 kg (%fat ¼ À4.7-6.9%) (Figure 2 ). The correlation was not significant (r ¼ À0.02, P ¼ 0.93) between the difference and mean of the two components.
Discussion
We assessed the ability of ADP to estimate FFM in children and adolescents with CF, using DEXA as the comparison technique. Our results demonstrated that FFM measurements from ADP and DEXA were in good agreement and suggest that ADP is a suitable technique for measuring FFM in this population. However, as we consider the limits of agreement as only fair and clinically significant, it is recommended that ADP and DEXA measurements should not be used interchangeably to monitor FFM in an individual. The correlation between the FFM difference and FFM mean for the two techniques was not significant, although there was a tendency for ADP to produce higher FFM values than DEXA in subjects with low levels of FFM. It was noted that age had a negative significant effect on the level of agreement between FFM derived from ADP and DEXA. This would suggest that ADP produces higher values than DEXA in younger children and lower values than DEXA in older children. This may be due to the age-dependent FFM density assumptions of Lohman (1989) and the combined error of the methods.
Although ADP is considered to be a simple method, not all subjects found the V TG measurement straightforward, and out of the total study population, only 56% of subjects were able to perform a measured V TG for the ADP measurement. The major reasons for subjects not producing a measured V TG were an inability to conform to the protocol within two attempts or refusing to attempt the procedure. It appears from our data that the ability to produce a measured V TG was independent of disease severity and age (data not shown).
In the 56% of subjects who were able to produce a measured V TG , it was found that there was no significant difference in FFM when predicted V TG vs measured V TG was used for the calculation. The magnitude of difference was not affected by lung function, age, sex or height (data not shown). From this we can conclude that for individuals with CF who have lung function within or close to normal limits, it is acceptable to use the Bod Pod s predicted V TG values for the estimation of FFM by ADP when one is unable to obtain a measured V TG . Whether these findings are also applicable to those with moderate or severe lung function has not been ascertained in this study. However, our analysis did not show a significant relationship between FEV 1 and the magnitude of difference between predicted and measured V TG , although greater subject numbers with severe and moderate lung disease are required to confirm whether predicted V TG can reliably be substituted for measured V TG . This is the first study to our knowledge that has attempted to validate ADP in children and adolescents with CF. In recent studies that have compared fatness measurements between ADP and DEXA in healthy children and adolescents, Lockner et al (2000) and Nicholson et al (2001) have demonstrated a significant negative mean difference between the methods, while a study by Nunez et al (1999) was consistent with the current study findings, showing no significant difference between the methods. Differences between findings may be attributed to interlaboratory method variation, differences in test conditions and the combined limitations of the methods (Fields et al, 2002) .
It is recognised that most body composition methods have limitations, including DEXA, which was used as a comparative method in this paper. A limitation of body fatness measurements from ADP lies in the conversion of body density to fat and FFM. In this study, the paediatric-specific equation of Lohman (1989) was employed to convert body density to FFM. This equation assumes the density of FFM for the subject's sex and age, but does not take into account the FFM density variations that may result from disease states, such as CF. These assumptions may lead to errors in the FFM prediction, depending on the extent that CF has affected the FFM density in the individual. Future studies are recommended to investigate the variations in FFM density of children and adolescents with CF, and the implications of these variations for ADP measurements.
Conclusion
This study investigated the use of ADP for measuring body composition in children and adolescents with CF. Results showed that FFM measurements from ADP and DEXA were in good agreement and that there was no consequence of using predicted V TG vs measured V TG in the calculation of FFM by ADP in individuals with CF who have normal lung function. It can be concluded that ADP is a promising Figure 2 The difference in FFM determined using predicted V TG and measured V TG against the mean FFM using both the methods. The bold line represents the correlation (r ¼ À0.02, P ¼ 0.93) between the difference in FFM and the mean FFM from the two methods.
technique for clinically determining body composition in children and adolescents with CF.
